XML 95 R75.htm IDEA: XBRL DOCUMENT v3.19.2
Legal, Regulatory Matters and Contingencies (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Jun. 26, 2019
USD ($)
May 22, 2019
USD ($)
May 10, 2019
company
employee
Jan. 22, 2018
item
product
Jun. 30, 2019
USD ($)
product
May 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
item
Oct. 31, 2018
item
Nov. 30, 2016
item
Dec. 31, 2016
customer
Jun. 30, 2019
Distributor
lawsuit
tranche
product
May 05, 2019
product
Jan. 16, 2019
product
Jun. 18, 2018
product
Jun. 07, 2018
product
Oct. 31, 2017
product
Oct. 06, 2017
product
State Attorneys General Inquiry into The Generic Pharmaceutical Industry                                  
Legal, Regulatory Matters and Contingencies                                  
Number of drugs | product                       40       13  
Number of officers | employee     1                            
Number of manufacturers and distributors | company     33                            
State Attorneys General Inquiry into The Generic Pharmaceutical Industry | Doxycycline Monohydrate                                  
Legal, Regulatory Matters and Contingencies                                  
Number of drugs | product                               1  
Texas Medicaid Investigation                                  
Legal, Regulatory Matters and Contingencies                                  
Litigation settlement amount payable to other party             $ 8,000                    
Payment to litigation settlement             $ 8,000                    
Government Pricing                                  
Legal, Regulatory Matters and Contingencies                                  
Payment to litigation settlement $ 9,400                                
Compliance reviews, number of customers | customer                   1              
Estimate of possible loss   $ 9,400                              
Damages sought, value   $ 8,100                              
Private Antitrust and Consumer Protection Litigation                                  
Legal, Regulatory Matters and Contingencies                                  
Number of drugs | product       30 18           18   30 15 14   6
Number of manufacturers and distributors | Distributor                     30            
Number of Tranches | tranche                     3            
Opt-out purchasers, number | item       3                          
Private Antitrust and Consumer Protection Litigation | Minimum                                  
Legal, Regulatory Matters and Contingencies                                  
Number of lawsuits | lawsuit                     100            
Shareholder Litigation                                  
Legal, Regulatory Matters and Contingencies                                  
Number of officers | item               2 2                
Litigation settlement amount payable to other party         $ 300,000 $ 300,000                      
Number of Shareholders | item             2